development & production
Commercialization of protein-based vaccines & biopharmaceuticals
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - WEDNESDAY MAY 30TH, 2012

GOLDEN HOPE MINES (TSXV:GNH) Confirms High Grade Intersection of 64.1 g/t Au (Gold) over 1m Read More 

  • The screen metallic analysis returned 82 g/t Au for an average grade of 93.5 g/t Au.
  • Two additional fire assays on the original pulp done prior to the screen metallic analyses returned 0.22 g/t Au and 0.12 g/t Au for an average fire assay grade of 0.41 g/t Au. The weighted average of all the fire assays and screen metallic assays from this 1-metre section in hole BD2011-184 is 64.1 g/t Au.

Sonomax® eers™ Custom Earbuds Announces Sponsorship of MUTEK 2012

CONTINENTAL ENERGY  Geothermal Energy Project Receives US$ 11.5 Million Grant Read More * Client

AGORACOM Launches Graphite Stocks Blog

Top Stories

  • FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

  • LOMIKO METALS (TSXV:LMK) Paul Gill Discusses Exploration Initiative with James West of Midas Letter Read More   |   *SPONSOR
  • GRAPHITE DEMAND Seen Surging from Fuel Cells, Nuclear Reactors, Graphene Read More

 

 

Message: Medicago to participate at prominent U.S. vaccine conference

Monopoly-money-bags_profile
Rank: [?]
President
Points: [?]
12753
Rating: [?]
Votes: 140 Score: 3.6
  • Currently 3.7/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Medicago to participate at prominent U.S. vaccine conference

posted on Aug 13, 08 04:55AM

QUEBEC CITY, Aug. 13 /CNW/ - Medicago Inc. (TSX-V: MDG) today announced that it will be presenting an update of its development of H5N1 vaccines generated from plant-made VLPs and unique technology platform, at the Targeted Immunotherapeutics and Vaccine Summit. This conference will be held from August 13-15, 2008, at the Royal Sonesta Hotel, Cambridge, Massachusetts.

Manon Couture, Ph.D., Project Leader, Product Development and Innovation will deliver a presentation on \"Innovative Influenza Virus-Like Particles Provides Protection against an H5N1 Challenge\" in a session entitled \"Innovating Vaccine Development,\" on Thursday August 14, 2008 at 10:45 a.m. EDT.

Additional information about the Targeted Immunotherapeutics and Vaccines Summit, including the full scientific program, can be viewed at http://www.healthtech.com\">www.healthtech.com

New Message

Please login to post a reply

AGORACOM Quick Tips

Breaking Small-Cap News Delivered to your Smart Phone! Grab our RSS Feed

President's D.D.

New feature: Hub Presidents can add important links here.